Clinical trials, drug development and research news
Tag
Drug ApprovalsThe MHRA has extended Casgevy to children from age five with severe sickle cell disease or thalassaemia, and NICE has widened NHS managed access to match.
30 October 2026
Drug ApprovalsThe MHRA has authorised Onswik, a basal insulin injected once a week, and NICE has backed it for NHS use, mainly to cut time spent helping people inject.
13 October 2026
Patient GuidesApproved does not always mean available. This guide explains how the FDA, MHRA and EMA review medicines, how NICE decides NHS funding, and why countries differ.
8 October 2026